Abstract
It is well known that long-term treatment with systemic steroids exerts immune-suppressive effects on the cellular immune system and increase the susceptibility to all types of intracellular infections. Inhaled corticosteroids have been the mainstay treatment for asthma for a long period and are generally accepted as safe with no or minimal systemic absorption. Although, these medications are usually used for long periods and sometimes in high doses, there is scarce evidence on their impact on cell mediated immunity, reactivation of tuberculosis in tuberculin skin test positive patients, innate and anti-viral immunity. Hereby, the studies on immune-suppressive effects of inhaled steroids are discussed focusing on cell mediated and antiviral immunity.
Keywords: Human, immune deficiency, immune system, infection, inhaled corticosteroids, side effects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Does Inhaled Corticosteroid Treatment Result in a Secondary Immune Deficiency Predisposing To Recurrent Infections?
Volume: 11 Issue: 3
Author(s): Nerin N. Bahceciler
Affiliation:
Keywords: Human, immune deficiency, immune system, infection, inhaled corticosteroids, side effects
Abstract: It is well known that long-term treatment with systemic steroids exerts immune-suppressive effects on the cellular immune system and increase the susceptibility to all types of intracellular infections. Inhaled corticosteroids have been the mainstay treatment for asthma for a long period and are generally accepted as safe with no or minimal systemic absorption. Although, these medications are usually used for long periods and sometimes in high doses, there is scarce evidence on their impact on cell mediated immunity, reactivation of tuberculosis in tuberculin skin test positive patients, innate and anti-viral immunity. Hereby, the studies on immune-suppressive effects of inhaled steroids are discussed focusing on cell mediated and antiviral immunity.
Export Options
About this article
Cite this article as:
N. Bahceciler Nerin, Does Inhaled Corticosteroid Treatment Result in a Secondary Immune Deficiency Predisposing To Recurrent Infections?, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012; 11 (3) . https://dx.doi.org/10.2174/1871523011202030217
DOI https://dx.doi.org/10.2174/1871523011202030217 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Surfactant-Associated Proteins: Structure, Function and Clinical Implications
Current Pediatric Reviews The Impact of Pharmaceutical Care Practice on the Practitioner and the Patient in the Ambulatory Practice Setting: Twenty-five Years of Experience
Current Pharmaceutical Design Kinin Receptors and Their Antagonists as Novel Therapeutic Agents
Current Pharmaceutical Design Anti-Selectin Therapy for the Treatment of Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) G Protein-Coupled Receptors and their Signaling Pathways: Classical Therapeutical Targets Susceptible to Novel Therapeutic Concepts
Current Pharmaceutical Design Discovery of 3,4-Diaminocyclobut-3-ene-1,2-dione-Based CXCR2 Receptor Antagonists for the Treatment of Inflammatory Disorders
Current Topics in Medicinal Chemistry Efficacy and Safety Evaluation of Fixed Dose Combination of Cefepime and Amikacin in Comparison with Cefepime Alone in Treatment of Nosocomial Pneumonia Patients
Current Clinical Pharmacology Atopic Dermatitis in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) The Inhibitory Co-Receptors: A Way to Save from Anergy the HIVSpecific T Cells
Current HIV Research Mapracorat, a Novel Non-Steroidal Selective Glucocorticoid Receptor Agonist for the Treatment of Allergic Conjunctivitis
Inflammation & Allergy - Drug Targets (Discontinued) Human A3 Adenosine Receptor as Versatile G Protein-Coupled Receptor Example to Validate the Receptor Homology Modeling Technology
Current Pharmaceutical Design The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Adenosine Receptors As Promising Therapeutic Targets for Drug Development in Chronic Airway Inflammation
Current Drug Targets The Life and Death of Protein Kinase C
Current Drug Targets Development and Validation of a Stability Indicating RP-UPLC Method for Simultaneous Determination of Rupatadine and Montelukast in Pharmaceutical Formulation
Current Pharmaceutical Analysis Editorial (Thematic Issue: Drug Delivery Australia)
Current Drug Delivery A Practical Comprehensive Approach to Management of Acute Decompensated Heart Failure
Current Cardiology Reviews RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes
Current Gene Therapy Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies
Current Pharmaceutical Biotechnology The Transcriptome in Blood: Challenges and Solutions for Robust Expression Profiling
Current Molecular Medicine